Department of Anesthesiology, Longyan First Affiliated Hospital of Fujian Medical University, Jiuyi North Road, Xinluo District, Longyan, 364000, Fujian, China.
BMC Anesthesiol. 2022 Jul 16;22(1):225. doi: 10.1186/s12871-022-01768-5.
To investigate the analgesic effect and rehabilitation quality of patients undergoing thoracoscopic wedge resection of the lung under erector spinae plane (ESP) block with dexmedetomidine combined with the same dose and different concentrations of ropivacaine.
Seventy patients undergoing thoracoscopic wedge resection were randomly divided into groups A (n = 35) and B (n = 35). To perform ESP block, the groups were administered dexmedetomidine (0.5 μg/kg) combined with 30 mL of 0.33% ropivacaine or 20 mL of 0.5% ropivacaine, respectively, half an hour before general anesthesia induction. We compared the onset time of anesthesia, the block level, and the duration of the block between the two groups. The number of compressions of the analgesic pump within 24 h and 48 h postoperatively and the time of the first compression were noted. The visual analog scale (VAS) scores of static and cough at 0.5 h, 6 h, 12 h, 24 h, and 48 h postoperatively were noted. Furthermore, the 40-item quality of recovery questionnaire (QoR-40) score was recorded at 24 h postoperatively. In addition, we noted the time taken to get out of the bed for the first time, the length of hospital stay, analgesia satisfaction, and the occurrence of related adverse reactions and complications within 48 h postoperatively.
The range of ESP block was wider in Group A than in Group B (P < 0.05). Group B had a significantly shorter onset time (P < 0.05) and lower static and cough VAS scores at 6 h and 12 h postoperatively (P < 0.05); this was associated with significantly fewer compressions of the analgesic pump within 24 h and 48 h postoperatively and significantly more time until the first compression of the analgesic pump was required (P < 0.05). Group B was associated with significantly superior QoR-40 scores 24 h postoperatively and significantly shorter time to get out of the bed for the first time than Group A (P < 0.05).
Dexmedetomidine combined with 0.5% ropivacaine for ESP block is better than 0.33% ropivacaine for overall analgesia and postoperative rehabilitation of patients undergoing thoracoscopic wedge resection.
ChiCTR2200058114 , Date of registration: 30/03/2022.
研究在竖脊肌平面阻滞(ESP 阻滞)下联合使用相同剂量不同浓度罗哌卡因的右美托咪定对行胸腔镜肺楔形切除术患者的镇痛效果和康复质量。
70 例行胸腔镜肺楔形切除术的患者被随机分为 A 组(n=35)和 B 组(n=35)。两组患者在全身麻醉诱导前半小时分别给予右美托咪定(0.5μg/kg)复合 30mL 0.33%罗哌卡因或 20mL 0.5%罗哌卡因行 ESP 阻滞。比较两组患者的麻醉起效时间、阻滞平面和阻滞持续时间。记录术后 24h 和 48h 内镇痛泵按压次数和首次按压时间。记录术后 0.5h、6h、12h、24h 和 48h 时的静息和咳嗽时视觉模拟评分(VAS)。术后 24h 记录 40 项康复质量问卷(QoR-40)评分。此外,记录两组患者首次下床时间、住院时间、镇痛满意度以及术后 48h 内相关不良反应和并发症的发生情况。
A 组 ESP 阻滞范围大于 B 组(P<0.05)。B 组麻醉起效时间明显短于 A 组(P<0.05),术后 6h 和 12h 静息和咳嗽 VAS 评分明显低于 A 组(P<0.05);B 组术后 24h 和 48h 内镇痛泵按压次数明显减少,首次按压镇痛泵所需时间明显延长(P<0.05)。B 组术后 24h QoR-40 评分明显高于 A 组,首次下床时间明显短于 A 组(P<0.05)。
与 0.33%罗哌卡因相比,在 ESP 阻滞中联合使用右美托咪定和 0.5%罗哌卡因可为行胸腔镜肺楔形切除术患者提供更好的整体镇痛效果和术后康复效果。
ChiCTR2200058114,注册日期:2022 年 3 月 30 日。